Home LiteratureArticle Details
PMID: 1472258 Published · ppublish English News

At age 2, gene therapy enters a growth phase.

Science (New York, N.Y.) ·Vol. 258 ·No. 5083 ·1992-10-30 ·Pages 744-6

Thompson L

Abstract

暂无摘要

MeSH Terms
Acquired Immunodeficiency Syndrome/therapy Adenosine Deaminase/deficiency DNA, Viral/genetics Genetic Therapy/trends Genetic Vectors HIV/genetics Humans Immunologic Deficiency Syndromes/therapy National Institutes of Health (U.S.) Neoplasms/therapy Retroviridae/genetics Transfection United States
Chemicals
DNA, Viral Adenosine Deaminase
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Thompson L
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
DOI
10.1126/science.1472258
Published
1992-10-30
Pages
744-6
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Corrections
ErratumIn
-
External Links
PubMed source DOI: 10.1126/science.1472258 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2